Mefenamic Acid Mercury Pharmaceuticals Ltd

Mefenamic Acid, the active ingredient in Mefenamic Acid Mercury Pharmaceuticals Ltd, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It treats mild to moderate pain, dysmenorrhea, and inflammatory musculoskeletal conditions in adults.

GNH USA supplies Mefenamic Acid Mercury Pharmaceuticals Ltd as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mefenamic Acid is an NSAID that reduces inflammation and pain in several common conditions.

- Mild to moderate pain: provides analgesic relief for headaches, dental pain, postoperative discomfort, and similar ailments. - Dysmenorrhea: lessens menstrual cramps and associated pelvic pain in women. - Inflammatory musculoskeletal conditions: decreases pain and swelling in arthritis, sprains, and soft‑tissue injuries.

Mefenamic Acid may cause a range of adverse reactions, from mild gastrointestinal discomfort to rare but serious complications.

Common Side Effects: - Nausea: occasional upset stomach. - Abdominal pain: mild to moderate discomfort. - Dyspepsia: indigestion or heartburn. - Diarrhea: loose stools. - Dizziness: transient light‑headedness. - Headache: mild to moderate.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment or reduced kidney function. - Severe skin reactions such as Stevens‑Johnson syndrome. - Anaphylaxis: life‑threatening allergic response. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Blood dyscrasias: rare blood cell abnormalities.

Before prescribing Mefenamic Acid, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Renal function assessment: check baseline kidney status, especially in the elderly. - Gastrointestinal risk: avoid in patients with a history of ulcers or bleeding. - Concomitant anticoagulants: use caution and monitor coagulation parameters. - Hypersensitivity: discontinue if allergic reactions occur. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Mefenamic Acid can alter the activity of several other medicines; interactions are grouped by clinical significance.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - ACE inhibitors: possible reduction in antihypertensive effect. - Lithium: elevated lithium serum concentrations. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: potential reduction in renal perfusion. - SSRIs or SNRIs: additive bleeding risk. - Corticosteroids: increased ulcer risk. - Antihypertensives: possible attenuation of blood‑pressure control. - Oral hypoglycemics: may affect blood‑sugar regulation.